Francis Chou’s Teva Pharmaceuticals TEVA Stock Holding History

Francis Chou’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,000	Closed	-$103K	–	21
2019 Q3	$103K	Hold	15,000	–	–	0.06%	22
2019 Q2	$138K	Hold	15,000	–	–	0.06%	24
2019 Q1	$234K	Hold	15,000	–	–	0.1%	25
2018 Q4	$231K	Hold	15,000	–	–	0.1%	26
2018 Q3	$323K	Hold	15,000	–	–	0.11%	25
2018 Q2	$365K	Hold	15,000	–	–	0.14%	25
2018 Q1	$256K	Hold	15,000	–	–	0.11%	23
2017 Q4	$284K	Sell	15,000 -490,000	-97%	-$7.37M	0.12%	24
2017 Q3	$8.89M	Hold	505,000	–	–	3.11%	10
2017 Q2	$16.8M	Buy	505,000 +290,000	+135%	+$8.98M	5.2%	8
2017 Q1	$6.9M	Buy	+215,000	New	+$7.34M	2.29%	14

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Francis Chou's TEVA Position: Q4 2019 in Review

Francis Chou sold out of Teva Pharmaceuticals (TEVA) in Q4 2019, closing a stake of 15,000 shares — an estimated $103K sold.

Francis Chou first reported a position in TEVA in Q1 2017 and held it in 11 quarters. The position peaked at $16.8M in Q2 2017. 437 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

Francis Chou reported no remaining Teva Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Francis Chou sold 15,000 Teva Pharmaceuticals shares in Q4 2019, an estimated $103K.
Francis Chou first reported a position in Teva Pharmaceuticals in Q1 2017 and held it in 11 quarters.
Francis Chou's Teva Pharmaceuticals position peaked at $16.8M in Q2 2017.
437 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2019.

Based on Chou Associates Management's 13F filing for Q4 2019, filed 4 Mar 2020.